Mirae Asset Global Investments Co., Ltd. Beam Therapeutics Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,457 shares of BEAM stock, worth $62,628. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,457
Previous 223,929
98.9%
Holding current value
$62,628
Previous $7.4 Million
99.23%
% of portfolio
0.0%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding BEAM
# of Institutions
230Shares Held
73.6MCall Options Held
283KPut Options Held
233K-
Farallon Capital Management LLC San Francisco, CA7.91MShares$202 Million0.9% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$201 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$195 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.63MShares$194 Million1.63% of portfolio
-
Arch Venture Management, LLC Chicago, IL5.44MShares$139 Million74.72% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.79B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...